IGFBP1 and hepatocellular carcinoma: A recent study identified a candidate marker, insulin like growth factor binding protein 1 (IGFBP1), in CTCs of 25 HCC patients, and this marker was shown to be correlated with the responsiveness to selective internal radiation therapy, which is a local ablative technique for HCC treatment [39].